## Core Concept
The question tests knowledge of antimicrobial agents used to treat infections caused by multi-drug resistant bacteria, specifically methicillin-resistant *Staphylococcus aureus* (MRSA) and vancomycin-resistant *Staphylococcus aureus* (VRSA). MRSA and VRSA are strains of *S. aureus* that have developed resistance to commonly used antibiotics, making treatment challenging. The correct answer must be an antibiotic that has efficacy against both MRSA and VRSA.

## Why the Correct Answer is Right
The correct answer, , is effective against both MRSA and VRSA. This antibiotic works by inhibiting bacterial protein synthesis. It is a *Staphylococcus* aureus-specific protein synthesis inhibitor that targets the 50S ribosomal subunit. Its unique mechanism of action makes it effective against strains of *S. aureus* that are resistant to other antibiotics, including vancomycin.

## Why Each Wrong Option is Incorrect
* **Option A:** is incorrect because, although it is used to treat MRSA infections, its efficacy against VRSA is limited or variable.
* **Option B:** is incorrect because it is primarily used for treating MRSA but not effective against VRSA.
* **Option C:** is incorrect because it is not commonly used for treating VRSA or MRSA infections due to its limited spectrum and potential side effects.

## Clinical Pearl / High-Yield Fact
A key point to remember is that the treatment of infections caused by multi-drug resistant bacteria like MRSA and VRSA often requires the use of antibiotics that are reserved for specific cases due to concerns about resistance development.

## Correct Answer Line
**Correct Answer: D. **